We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant Schizophrenia (COES)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00169065
First Posted: September 15, 2005
Last Update Posted: April 7, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institute of Mental Health (NIMH)
Dartmouth-Hitchcock Medical Center
Commonwealth Research Center, Massachusetts
Eli Lilly and Company
Information provided by (Responsible Party):
AlanGreen, National Institute of Mental Health (NIMH)
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2002
  Primary Completion Date: June 2002 (Final data collection date for primary outcome measure)